Literature DB >> 17240128

Enhanced in vitro permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles.

Ann Marie Kaukonen1, Leena Laitinen, Jarno Salonen, Jaani Tuura, Teemu Heikkilä, Tarja Limnell, Jouni Hirvonen, Vesa-Pekka Lehto.   

Abstract

The combined release and permeation behavior of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles was studied in order to evaluate the potential of TCPSi-loading to improve permeation of furosemide, a BCS class IV compound. Permeation was studied across Caco-2 monolayers at pH 5.5, 6.8 and 7.4 from drug solutions and TCPSi particles. TCPSi-loaded furosemide (39% w/w) exhibited improved dissolution from the microparticles with greatly diminished pH dependence. At pH 5.5, where furosemide solubility restricted the amount that could be dissolved in the control solution to less than 30% of the dose contained in the TCPSi particles, the flux of TCPSi-loaded furosemide across Caco-2 monolayers was over fivefold compared to pre-dissolved furosemide. The improved permeation could be confirmed also from dose-corrected (% dose-permeated) results. At pH 6.8 and pH 7.4, where corresponding doses could be used in control solutions, more than fourfold permeability values were obtained with TCPSi-loaded furosemide. Effects on transepithelial electrical resistance (TEER) and mannitol permeability were monitored and suggest that monolayer integrity was not compromised by the drug-loaded TCPSi microparticles. The improved permeation observed from furosemide-loaded TCPSi particles suggests that the high local concentrations provided by the enhanced dissolution properties of TCPSi-loaded furosemide could prove beneficial for absorption.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17240128     DOI: 10.1016/j.ejpb.2006.11.021

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  6 in total

1.  Mesoporous silicon (PSi) for sustained peptide delivery: effect of psi microparticle surface chemistry on peptide YY3-36 release.

Authors:  Miia Kovalainen; Juha Mönkäre; Ermei Mäkilä; Jarno Salonen; Vesa-Pekka Lehto; Karl-Heinz Herzig; Kristiina Järvinen
Journal:  Pharm Res       Date:  2011-10-27       Impact factor: 4.200

2.  Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.

Authors:  Swati Nagar; Richard C Korzekwa; Ken Korzekwa
Journal:  Mol Pharm       Date:  2017-07-31       Impact factor: 4.939

Review 3.  Porous silicon in drug delivery devices and materials.

Authors:  Emily J Anglin; Lingyun Cheng; William R Freeman; Michael J Sailor
Journal:  Adv Drug Deliv Rev       Date:  2008-04-10       Impact factor: 15.470

4.  In vitro dissolution methods for hydrophilic and hydrophobic porous silicon microparticles.

Authors:  Juha Mönkäre; Joakim Riikonen; Elina Rauma; Jarno Salonen; Vesa-Pekka Lehto; Kristiina Järvinen
Journal:  Pharmaceutics       Date:  2011-06-21       Impact factor: 6.321

5.  Assessing the axonal translocation of CeO2 and SiO2 nanoparticles in the sciatic nerve fibers of the frog: an ex vivo electrophysiological study.

Authors:  Georgia Kastrinaki; Christos Samsouris; Efstratios K Kosmidis; Eleni Papaioannou; Athanasios G Konstandopoulos; George Theophilidis
Journal:  Int J Nanomedicine       Date:  2015-11-19

6.  Crystallographically Determined Etching and Its Relevance to the Metal-Assisted Catalytic Etching (MACE) of Silicon Powders.

Authors:  Kurt W Kolasinski; Bret A Unger; Alexis T Ernst; Mark Aindow
Journal:  Front Chem       Date:  2019-01-07       Impact factor: 5.221

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.